23andMe to Sell DNA Data of Parkinson's Customers to Genentech for $60 Million 23andMe has struck a $60 million deal with Genentech to analyze the genetic data of about 3,000 of its customers. The data will be used to develop a new treatment for Parkinson's disease. by Rhodi Lee